CoChat

Clinical and prognostic role of annexin A2 in multiple myeloma

Open access
Seckinger, Anja, Meiβner, Tobias, Moreaux, Jérôme, Depeweg, Daniela, Hillengass, Jens, Hose, Katja, Rème, Thierry, Rösen-Wolff, Angela, Jauch, Anna, Schnettler, Reinhard, Ewerbeck, Volker, Goldschmidt, Hartmut, Klein, Bernard, Hose, Dirk · 2012 · Blood
Cited by 157

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Annexin A2 (ANXA2) promotes myeloma cell growth, reduces apoptosis in myeloma cell lines, and increases osteoclast formation. ANXA2 has been described in small cohorts of samples as expressed by myeloma cells and cells of the BM microenvironment. To investigate its clinical role, we assessed 1148 samples including independent cohorts of 332 and 701 CD138-purified myeloma cell samples from previously untreated patients together with clinical prognostic factors, chromosomal aberrations, and gene expression–based high-risk scores, along with expression of ANXA2 in whole BM samples, stromal cells, osteoblasts, osteoclasts, and BM sera. ANXA2 is expressed in all normal and malignant plasma cell samples. Higher ANXA2 expression in myeloma cells is associated with significantly inferior event-free and overall survival independently of conventional prognostic factors and is associated with gene expression–determined high risk and high proliferation. Within the BM, all cell populations, including osteoblasts, osteoclasts, and stromal cells, express ANXA2. ANXA2 expression is increased significantly in myelomatous versus normal BM serum. ANXA2 exemplifies an interesting class of targetable bone-remodeling factors expressed by normal and malignant plasma cells and the BM microenvironment that have a significant impact on survival of myeloma patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2012-03-415588

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 157

Metadata

Authors
Seckinger, A., Meiβner, T., Moreaux, J., Depeweg, D., Hillengass, J., Hose, K., Rème, T., Rösen-Wolff, A., Jauch, A., Schnettler, R., Ewerbeck, V., Goldschmidt, H., Klein, B., & Hose, D.
Venue
Blood
Published
2012-08-02
Volume
120
Issue
5
Pages
1087-1094
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W1965287545
Cited by
157
References
3
FWCI
4.42
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical and prognostic role of annexin A2 in multiple myeloma. https://app.cochat.ai/papers/10.1182/blood-2012-03-415588
The paper
Seckinger, A., Meiβner, T., Moreaux, J., Depeweg, D., Hillengass, J., Hose, K., Rème, T., Rösen-Wolff, A., Jauch, A., Schnettler, R., Ewerbeck, V., Goldschmidt, H., Klein, B., & Hose, D. (2012). Clinical and prognostic role of annexin A2 in multiple myeloma. Blood. https://doi.org/10.1182/blood-2012-03-415588

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.